Assessment Of GBR In Buccal Dehisence In Implant Patients: An Original Research

Authors

  • Dr. Shubha Joshi, Dr. Nivedita Dixit, Dr. Mutthineni Lakshmi Durga Chowdary, Dr. Hymasree Betha, Dr. Mazen Ahmad Almasri, Dr. Aravinth R, Dr. Anita Biswalo

DOI:

https://doi.org/10.47750/pnr.2022.13.S10.693

Abstract

Purpose: GBR is used to treat dehiscence-type and fenestration type defects in implant patients, but research suggests it may be better without a bone graft. Therefore the study aimed to asses the GBR in buccal dehiscence in implants.

Methods: This research enrolled 20 male or female patients with an anticipated osseous deficiency measuring no more than 5 mm in height. All patients received thorough dental care and were in good general health condition. Two groups of patients were studied: spontaneous healing (SH) and guided bone regeneration (GBR). Clinical measurements included implant survival, plaque index, probing pocket depths, sulcus bleeding index, and mucosa level. SAS V9.4 was employed to perform the statistical analysis.

Results: The experiment involved 25 implants placed in 20 individuals, with 10 patients in the directed bone regeneration group (GBR) and 10 patients in the spontaneous healing group (SH). Implants achieved primary stability after insertion, with no significant difference in vertical defect height. The implant and crown survival rate was 100% after 18 months, with no serious biologic or prosthetic complications. Probing pocket depths mesio-orally were the only peri-implant parameter to show a statistically significant difference between the test and control sites.

Conclusion: Minor bone dehiscence defects that allowed for spontaneous healing resulted in good implant survival rates but increased vertical bone loss at the buccal face. GBR surgeries appear to improve the buccal bone stability of implants with buccal bony dehiscence defects.

Downloads

Published

2022-12-31 — Updated on 2022-12-31

Issue

Section

Articles

How to Cite

Assessment Of GBR In Buccal Dehisence In Implant Patients: An Original Research. (2022). Journal of Pharmaceutical Negative Results, 5675-5678. https://doi.org/10.47750/pnr.2022.13.S10.693